The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“the inclusion of BMD testing was associated with a 52% increase in osteoporosis-related medical visits (odds ratio: 1.52, 95% confidence interval [CI]: 1.42-1.62)”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
2 independent labs in 2 countries
Funder: Korea Medical Institute
Humans6
What did studies of bone mineral density testing find?
1
Studies of bone mineral density testing measured one outcome, osteoporosis-related medical visits.
Osteoporosis-related medical visits
↑upin humans1OR 1.52
1 study
Bone mineral density testing is linked with higher osteoporosis-related medical visits in humans (+52% (OR 1.52, 95% CI 1.42–1.62)).
Bone mineral density testing is associated with subsequent fragility fracture in humans after initial low-energy distal radius fracture (4.4% (95% CI, 3.7%–5.2%) with testing versus 6.2% (95% CI, 5.9%–6.6%) without testing).
Among 34,758 adults, 29.9% received bone density testing within a year of transplantation, compared with 63.8% over a median 8.4-year follow-up.Among 34,758 adults, 29.9% received bone density testing within a year of transplantation, compared with 63.8% over a median 8.4-year follow-up.